Adverum Biotechnologies Faces Investigation and Financial Restatements

Posted Apr 4 by Two Blokes

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) is under investigation by Pomerantz LLP for potential securities

Source: Two Blokes Trading

Guess?, Inc. (NYSE: GES) Surpasses Financial Expectations with Strong Earnings and Revenue Growth

Posted Apr 4 by Two Blokes

Guess?, Inc. (NYSE: GES) reported earnings per share of $1.48, beating estimates and showcasing strong market

Source: Two Blokes Trading

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Faces Financial Challenges Despite Strategic Initiatives

Posted Apr 4 by Two Blokes

Lifecore Biomedical reported an EPS of -$0.47, missing the estimated EPS by a significant margin. The company

Source: Two Blokes Trading

Dollarama Inc. (PNK:DLMAF) Surpasses Q4 Earnings and Revenue Estimates

Posted Apr 4 by Two Blokes

Earnings per share of $0.963, beating the estimated $0.901. Revenue reached approximately $1.29 billion, surp

Source: Two Blokes Trading

The Greenbrier Companies, Inc. (NYSE: GBX) Q2 Fiscal 2025 Earnings Preview

Posted Apr 4 by Two Blokes

Earnings Expectations: Analysts predict an EPS of $1.78 and revenue of approximately $898.5 million for Q2 fi

Source: Two Blokes Trading

APA Corporation's Director Buys Shares Amidst Stock Challenges

Posted Apr 4 by Two Blokes

Insight into APA Corporation's Recent Stock Purchase and Market Performance On April 3, 2025, Joung Chansoo

Source: Two Blokes Trading

NVIDIA Faces Headwinds on GPU Pricing, HSBC Downgrades to Hold

Posted Apr 3 by Two Blokes

NVIDIA (NASDAQ:NVDA) saw its rating lowered from Buy to Hold by HSBC analysts, who also reduced the price targ

Source: Two Blokes Trading

Apple Tariffs Could Hit Profits Hard, Price Hikes Likely Ahead, Says Raymond James

Posted Apr 3 by Two Blokes

Raymond James reiterated its Outperform rating and $250 price target on Apple (NASDAQ:AAPL), but warned that l

Source: Two Blokes Trading

UBS Sticks to Bullish View on CME Group, Shares Up 3%

Posted Apr 3 by Two Blokes

UBS is holding firm on its Buy rating for CME Group (NASDAQ:CME), maintaining a $290 price target as strong tr

Source: Two Blokes Trading

UBS Doubles Down on Kohl’s Sell Rating, Sees Long Road Ahead Despite New Initiatives

Posted Apr 3 by Two Blokes

UBS has reaffirmed its Sell rating on Kohl’s (NYSE:KSS) and maintained a $5.00 price target, signaling continu

Source: Two Blokes Trading

Eastman Chemical Upgraded to Outperform on Strong U.S. Exposure and Improving Earnings Outlook

Posted Apr 3 by Two Blokes

Mizuho raised its rating on Eastman Chemical (NYSE:EMN) from Neutral to Outperform, assigning a new price targ

Source: Two Blokes Trading

Citi Upgrades BJ’s Wholesale to Buy, Shares Rise 2%

Posted Apr 3 by Two Blokes

BJ's Wholesale Club (NYSE:BJ) received a bullish upgrade from Citi analysts, who raised the stock from Neutral

Source: Two Blokes Trading